Mersana Therapeutics

2 followers

‌

Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.

Industries

Employees

51-200

Links


Org chart

Martin Huber
President & Chief Executive Officer
Collapse
Brian C. Deschuytner
Chief Operating Officer & Chief Financial Officer
Timothy B. Lowinger
Chief Science & Technology Officer
Alejandra Carvajal
Svp, Chief Legal Officer
Mohan Bala
SVP & Chief Development Officer
Chuck Miller
Senior Vice President, Regulatory Affairs
Rishi Bhattacharjee
Vice President, Clinical Quality Assurance
Robert Burger
Vice President, Clinical Development
Adi Reske
Executive Director, Scientific Communications, Medical Affairs
Bradley J. Sumrow
Executive Medical Director
Sandra F. McManus
Vice President Of Quality, Manufacturing
Jon Haskins
Executive Director, Product Strategy & Program Leadership
Annette Kranepool
Sr. Director, Talent Acquisition & HRBP
Bethany Hanson
Manager, Executive Administration
Jennifer Tate
Manager, Executive Administration

Board & advisors

David Mott
Chairman
Andrew Hack
Director
Christoph Lengauer
Scientific Advisor
Howard A. Skip Burris III
Scientific Advisor
Peter A. Kiener
Scientific Advisor
K. Dane Wittrup
Scientific Advisor